Mining of Novkitasetaline, a New Sulfur-Containing Antimalarial β-Carboline Alkaloid, from Streptomyces sp. PRh3 by Functional Ribosome Engineering Directed Heterologous Expression
Xingyu Chen, Xiaohui He, Yanmin Wang, Yangping Feng, Zihan Wang, Chunhui Song, Xinyu Yu, Yunchang Xie, Whei-Fen Wu · 2025
Read Mining of Novkitasetaline, a New Sulfur-Containing Antimalarial β-Carboline Alkaloid, from Streptomyces sp. PRh3 by Functional Ribosome Engineering Directed Heterologous Expression by Xingyu Chen, Xiaohui He, Yanmin Wang, Yangping Feng, Zihan Wang, Chunhui Song, Xinyu Yu, Yunchang Xie, Whei-Fen Wu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12735770.txt.
Description
Xingyu Chen and co-authors wake a shy microbe strain to mine a new antimalarial in a 2025 study. The soil bacterium Streptomyces sp. PRh3, drawn from wild rice, had gone quiet in the lab. Ribosome engineering with rifampicin first stirred it to make two known beta carboline compounds.
A gene cluster named ksl then went into the stirred strain for outside expression. The pairing yielded a fresh sulfur bearing molecule, novkitasetaline, built as a tryptamine swapped kitasetaline kin. Lab tests showed it stalls malaria parasites, drug sensitive and resistant alike, late in their growth cycle. The find marks a lead worth chasing.
Catalog record
| CREATOR | Xingyu Chen, Xiaohui He, Yanmin Wang, Yangping Feng, Zihan Wang, Chunhui Song, Xinyu Yu, Yunchang Xie, Whei-Fen Wu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |